Status:

UNKNOWN

Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.

Lead Sponsor:

Medical University of Silesia

Conditions:

Iron-deficiency

Iron Deficiency Anemia

Eligibility:

All Genders

18+ years

Brief Summary

Anemia is a common health problem. Depending on a geographical region, anemia affects even 50% of population. Among patients admitted to the intensive care unit (ICU) anemia may affect as much as 66% ...

Eligibility Criteria

Inclusion

  • diagnosis of sepsis or septic shock according to the third international definition and appropriate diagnostic criteria

Exclusion

  • active bleeding
  • erythrocyte mean corpuscular volume (MCV) above the reference range
  • diagnosed thalassemia or suspicion of thalassemia based on Mentzer index \[9\]
  • pregnancy

Key Trial Info

Start Date :

September 24 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT05217836

Start Date

September 24 2021

End Date

December 31 2022

Last Update

February 1 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Clinical Center

Katowice, Poland, 40-752

Iron Metabolism Disorders in Patients With Sepsis or Septic Shock. | DecenTrialz